Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on July 21, 2021, to report its financial results for the second quarter ended June 30, 2021. The filing primarily includes a press release detailing these results, which is furnished as an exhibit. Investors should note that the information provided in this 8-K, including the press release, is considered furnished and not filed for the purposes of Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same legal implications as a formally filed document regarding liability for misstatements or omissions. The report also contains forward-looking statements, which offer management's current expectations about future performance and operations. Investors are cautioned that these statements are subject to various risks and uncertainties that could cause actual results to differ materially. The company highlights potential impacts from public health emergencies, healthcare cost trends, regulatory changes (including the Affordable Care Act), economic conditions, competitive pressures, and operational risks, among others. While specific financial figures are not detailed in the 8-K text itself, the furnished press release would contain these critical performance indicators for the quarter.
Key Highlights
- 1Elevance Health (Anthem, Inc.) announced its Q2 2021 financial results via an 8-K filing on July 21, 2021.
- 2The primary content of the filing is a press release (Exhibit 99.1) detailing the company's financial performance for the quarter ended June 30, 2021.
- 3Information furnished in this 8-K is not deemed 'filed' for legal liability purposes under Section 18 of the Securities Exchange Act of 1934.
- 4The report includes standard forward-looking statements, cautioning investors about potential deviations from projected outcomes.
- 5Key risk factors discussed include the impact of public health emergencies (like COVID-19), healthcare cost trends, and regulatory environments.
- 6Other significant risks mentioned involve competitive pressures, provider contract negotiations, enrollment changes, and potential data privacy issues.
- 7The filing also touches upon risks related to government programs (Medicare/Medicaid), quality ratings, PBM business, and potential litigation or investigations.